• Crown NL Bidco agreed on October 21, 2026, to acquire all Qiagen shares through a cash offer of EUR 46.50 per share.
• The managing and supervisory boards unanimously support the transaction, which requires acceptance of at least 50% plus one share and regulatory clearances.
• Committed equity financing totals EUR 5.97 billion; debt commitments cover the remaining funding requirements, with closing not conditional on financing.
• The buyer aims to secure full ownership and delist the shares from the New York and Frankfurt stock exchanges.
• Qiagen faces a EUR 150 million termination fee in specified circumstances; the buyer owes EUR 300 million if regulatory conditions fail.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qiagen NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950103-26-016060), on October 23, 2026, and is solely responsible for the information contained therein.